Oncology Doctors in Madrid, Spain

Dr. Antonio Cubillo emerges as a prominent figure in the realm of oncology, bringing over two decades of expertise to the forefront. Currently serving as the head of the Center of Medical Oncology at the Centro Integral Oncológico Clara Campal and an associate professor of oncology at the University CEU San Pablo, Madrid, Dr. Cubillo stands as a renowned oncologist with a specialization in sarcoma, gastrointestinal, and genitourinary tumors. His extensive experience is underscored by his role as a specialist at the MD Anderson International Hospital in Madrid, where he focuses on solid tumors and serves as the coordinator of the oncology emergency service. Dr. Cubillo's educational journey includes earning his medical degree from the Universidad Autónoma de Madrid in Spain in 1994. Complementing his medical qualifications, he holds a master's degree in Palliative and Supportive Care and has undergone postgraduate training in Medical Oncology, obtaining certification in the field. Actively contributing to the advancement of oncological knowledge, Dr. Cubillo is associated with clinical trials at Clinica CONIM in Madrid, Spain, showcasing his commitment to cutting-edge research and patient care. His memberships in esteemed organizations such as the Spanish Society of Medical Oncology, the Treatment Group of GI Tumors, and the Spanish group of Sarcoma research further attest to his dedication to collaborative and comprehensive oncological care. Dr. Cubillo's prolific career is enriched by his involvement as an investigator in over 100 clinical trials, numerous scientific articles, book chapters, and abstracts, solidifying his position as a respected authority in the field of oncology.

Dr. Blanca Lopez Ibor stands as a distinguished figure in the field of Oncology and Hematology Oncology, contributing over 35 years of expertise to the medical landscape. Currently serving as the director of the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital in Madrid, Spain, Dr. Lopez Ibor specializes in the comprehensive care of children and adolescents facing various challenging conditions, including Ewing's Sarcoma, Leiomyosarcoma, Sarcoma, Leucosis, Multiple Myeloma, Leukemia, Non-Hodgkin's Lymphoma, and Lymphoma. Her stellar reputation is underscored by a perfect 5 out of 5 rating from those who have sought her expertise. Educationally, Dr. Lopez Ibor earned her degree in Medicine from the esteemed Complutense University of Madrid, where she completed her residency in Pediatrics. Further enhancing her specialization, she pursued Pediatric Hematology and Oncology at the University of Maryland in the United States, culminating in the title of Doctor of Medicine from the University of Barcelona. Dr. Lopez Ibor's impressive career includes leadership roles such as the head of the Pediatric Hematology and Oncology Unit at Hospital Montepríncipe since 2006 and prior leadership at Hospital Universitario Clínica San Rafael. In addition to her impactful clinical contributions, Dr. Lopez Ibor is an active member of prominent national and international societies, including ASH (American Society of Hematology), ASPHO (American Society of Pediatric Hematology/Oncology), SIOP (International Society of Paediatric Oncology), and AEP (Spanish Association of Pediatrics). Her commitment to advancing knowledge is evident through her authorship of numerous publications, both at the national and international levels. Dr. Blanca Lopez Ibor continues to be a beacon of expertise and compassion in the realm of pediatric hematology and oncology.

Dr. Carme Ares leads a distinguished career spanning over 30 years. Holding a Medical Degree from the Autonomous University of Barcelona since 1991, Dr. Ares further solidified her expertise by earning a Ph.D. in 2018. Notably, she enriched her skills during a tenure as a Senior Consultant at the esteemed Proton Therapy Center at Massachusetts Hospital in Boston, USA, in 2006. Following this, she contributed to the field as a Senior Radio Oncologist at the Paul Scherrer Institute in Switzerland. Since 2018, Dr. Ares has held the position of Senior Specialist in Radiooncology at MAASTRO-ZON-PTC Clinic in the Netherlands. Specializing in Oncology, Dr. Ares receives a majority of referrals for the treatment of conditions such as Glioblastoma, Meningioma, Retinoblastoma, Kidney Cancer, Prostate Cancer, Liver Cancer, and Lung Cancer. Her commitment to personalized patient care is reflected in the provision of free consultations, personalized treatment plans, and the assurance of priority appointments. Dr. Ares' dedication to advancing medical knowledge is evident through her authorship of various books and presentations at national and international conferences. Experience excellence in cancer care under the guidance of Dr. Carme Ares at the forefront of the Quironsalud Proton Therapy Center.

Prof. Dr. Daniel Alejandro Maza, a distinguished Spanish radio-oncologist with an illustrious 36-year career, is renowned for his expertise in IMRT, Brachytherapy, and medical physics. Graduating from the University of Buenos Aires in 1984, he later specialized at the University of Argentina and pursued additional education in radiation oncology at the Institut Curie Paris in 2018. Dr. Maza's professional journey includes significant roles as a radio-oncology specialist and professor at prestigious institutions such as Massachusetts Hospital, Harvard Medical School, and Indiana University in the USA. His wealth of experience is underscored by memberships in esteemed organizations, including the Particle Therapy Co-Operative Group (PTCOG), The European Society for Therapeutic Radiology and Oncology (ESTRO), the French Society for Physical Medicine (SFPM), and the Phelan-McDermid Syndrome Foundation (PMSF). Dr. Maza's extensive contributions to the field are reflected in his numerous authored books and articles, solidifying his status as a respected figure in oncology.

Dr. Elia Del Cerro Peñalver is a distinguished radiologist, renowned for her extensive expertise in advancing contemporary radiotherapy techniques in Spain. Currently serving as the Head of the Radiation Oncology Service at Quirónsalud Madrid University Hospital, Dr. Del Cerro is a trailblazer in implementing innovative methods such as High Dose Rate Brachytherapy, Intensity-Modulated Radiotherapy (IMRT), and stereotactic systems for both brain and body applications. Specializing in the treatment of patients with prostate cancer and gynecological cancer, she employs the latest techniques to provide optimal care. Dr. Elia Del Cerro Peñalver earned her degree in Medicine and Surgery from the Autonomous University of Madrid in 1990. She completed her specialization in Radiation Oncology via MIR in 1994, followed by residency and training at the University Hospital of La Princesa in Madrid. To further enrich her skills, she underwent additional training at Princess Margaret Hospital in Toronto, Canada, and MD Anderson Cancer Center in Houston, Texas, USA. Over the years, Dr. Del Cerro has held various positions, including Adjunct Physician of Radiation Oncology at Ruber International Hospital and MD Anderson Spain. Since 2006, she has been the Head of the Radiation Oncology Service at Hospital Universitario Quiron Salud Madrid, and since 2018, she has served as the Head of the Radiation Oncology Department at Hospital La Luz within the Quirónsalud Group. Dr. Elia Del Cerro is a proud member of prestigious organizations such as the American Society for Radiation Oncology (ASTRO), the International Senologic and Oncologic Scientific Community (ISOSC), and the UPMC International Oncology organization. Her contributions to the field extend to numerous national and international publications in the medical scientific literature.

Dr. Javier Cortes Castan is a distinguished oncologist specializing in breast malignancy and gynecological tumors. With over 20 years of experience, he has established himself as a leading figure in the field, renowned for his expertise and dedication to advancing cancer research. Dr. Cortes Castan's primary focus lies in pioneering research aimed at revolutionizing the treatment of breast cancer, with a vision of significantly improving outcomes for patients in the near future. Educated at the Autonomous University and the University of Navarra, Dr. Cortes Castan underwent specialized training in oncology, during which he actively contributed to the Sector of Cancer. Currently, he serves as a key figure in the Medical Oncology sector at the Vall d'Hebron Hospital in Barcelona and leads the breast malignancy project at the IOB Cancer center. Additionally, he holds the position of Chief of the Breast Oncology unit at the prestigious Ruber International Hospital in Madrid. Dr. Cortes Castan's remarkable contributions to oncology include leading roles in the development of cutting-edge medications and significant involvement in numerous cancer research projects worldwide. He is a member of various international Cancer Societies and the Scientific society ESMO, demonstrating his commitment to advancing the field of oncology through collaboration and innovation.

Dr. Juan Castro, an esteemed oncologist and Head of the Radiophysics and Radiological Protection Service at the Quironsalud Proton Therapy Center in Madrid, Spain, brings 18 years of extensive experience in the field of oncology. Specializing in the treatment of a diverse range of cancers, Dr. Castro has garnered a stellar reputation, with a perfect 5 out of 5 rating from a majority of patients who seek his expertise. His areas of focus include Rectal Cancer, Chondrosarcoma, Adenocarcinoma, Brain Cancer, Bladder Cancer, Bone Cancer, Prostate Cancer, Gallbladder Cancer, Cancer of the Soft Palate, Breast Cancer, Laryngeal Cancer, and Bowel Cancer. Dr. Castro's educational journey commenced with a degree in Physical Sciences from the University of Santiago de Compostela in 2002, followed by specialization in Hospital Radiophysics at the 12 de Octubre University Hospital in Madrid from 2005 to 2008. Continuing his academic pursuits, he pursued doctoral courses in Radiological Sciences at the Complutense University of Madrid. Throughout his illustrious career, Dr. Castro has played pivotal roles in various capacities, including serving as Deputy Radiophysicist in the Radiophysics Section of the Radiation Oncology Service at the Hospital Universitario 12 de Octubre. His current role as the Head of the Radiophysics and Radiological Protection Service underscores his leadership and expertise at the forefront of cutting-edge cancer treatment.

Dr. Lisardo Ugidos De La Varga is a highly accomplished oncologist contributing significantly to the field of medical oncology in Madrid, Spain. With extensive experience and a profound commitment to advancing cancer treatment, Dr. Ugidos is currently serving as the Director of Clinical Research at the Vithas Oncology Institute (IOV) in Madrid. His leadership at IOV encompasses three prominent medical centers: Vithas Madrid Arturo Soria University Hospitals, Vithas Madrid La Milagrosa, and Vithas Madrid Aravaca, reinforcing the institute's healthcare strategy focused on specialized institutes. Dr. Ugidos specializes in various aspects of oncology, including lung cancer, head and neck cancer, immunotherapy, molecular targets, oncogeriatrics, and clinical trials. His dedication extends beyond clinical practice, as he also holds the position of President of TOMAKAKU, a multidisciplinary collaborative group on head and neck cancer comprising specialists from the Community of Madrid and Castilla-La Mancha. Dr. Ugidos' remarkable career involves significant contributions to translational research, evidenced by his fellowship in translational oncology at the Methodist Hospital in Houston, USA. Having participated in numerous clinical trials related to immunotherapy and targeted therapies, Dr. Ugidos stands as a key figure in advancing treatment modalities. His comprehensive approach to patient care, including optimizing screening for elderly patients and enhancing their quality of life during antitumor treatments, reflects his commitment to improving cancer care. Born in León in 1977, Dr. Lisardo Ugidos De La Varga graduated in Medicine from the Autonomous University of Madrid in 2001, specializing in Medical Oncology at the Ramón y Cajal Hospital in Madrid between 2002 and 2006. His journey encompasses diverse medical roles, with a focus on delivering exceptional oncological care and pioneering research in the quest for innovative cancer therapies.

Dr. Raul Matute Martin stands as a distinguished figure in the realm of radiation oncology, holding a pivotal role at the Quironsalud Proton Therapy Center in Madrid, Spain. With a focus on oncology, Dr. Matute Martin has garnered a notable 4 out of 5 rating, with the majority of patients seeking his expertise for conditions such as Lip Cancer, Large Intestine (Colon Cancer), Rectal Cancer, Sigmoid Cancer, Cancer of the Small Intestine, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Breast Cancer, Cancer of the vulva, Adrenal Cancer, and Esophageal cancer. Educationally, Dr. Raul Matute Martin has an impressive background, having completed his undergraduate studies in medicine with a specialization in radiation oncology. His commitment to advancing medical technologies led him to pursue a fellowship degree in Medical Radiation, delving into the intricacies of radiation therapy and its applications. Throughout his professional journey, Dr. Martin has emerged as a leader in the field, contributing significantly to the planning and optimization of radiation treatment plans. His leadership extends to various proton therapy centers, including his instrumental role in establishing the Proton Therapy Center Madrid as a premier facility in Europe. Dr. Matute Martin is actively engaged in professional organizations, holding memberships in the International Society for Proton Therapy, the European Society for Radiotherapy and Oncology, and the National Association for Medical Physics. His dedication and expertise continue to shape the landscape of cancer treatment and patient care, both nationally and internationally.

Dr. Raymond Miralbell stands at the forefront of medical oncology with an impressive 47-year career. Renowned for his expertise in radiotherapy and proton therapy, Dr. Miralbell has become a prominent figure in Spain's healthcare landscape. Graduating with a Medical Degree from the Autonomous University of Barcelona in 1977, he further honed his skills during his residency at St. Paul Hospital in Barcelona from 1979 to 1984. Dr. Miralbell's illustrious career includes pivotal roles such as serving as a senior resident at the Radiation Oncology Department at Harvard University (1987-1989), Deputy Head of the Radio-Oncology Department at the University of Geneva (1991-2006), and Head of the Swiss Proton User Group (2000-2008). His academic contributions also extend to his appointment as an Associate Professor at the Faculty of Medicine at the University of Geneva from 2006 to 2019. Currently, he holds the position of senior Medical Oncologist at the Quironsalud Proton Therapy Center, solidifying his commitment to advancing cancer care. Dr. Miralbell's impact is not only felt in clinical practice but is also reflected in his extensive publications, including numerous chapters, monographs, and over 170 articles in scientific journals. Experience the pinnacle of medical expertise with Dr. Raymond Miralbell at the Quironsalud Proton Therapy Center.